ET124 treatment effectively increased microglial miR-124 levels and prevented alterations in their morphology, as well as in the expression of P2RY12, TREM2, HLA-DRA, and HMGB1. Such effects minimized the AD-related molecular signature and supported the preservation of neuroreparative and functional microglia. This evidence concerns the gene HMGB1 and Alzheimer disease.